 ARDEN HILLS, Minn., July 27, 2020 GLOBE NEWSWIRE -- IntriCon Corporation NASDAQ: IIN, a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 second-quarter results on Monday, August 10, 2020, at market close. Following the release, IntriCons management team will host a conference call on the same day, beginning at 4:00 p.m. CT5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing 866-795-7248 for domestic callers or 470-495-9160 for international callers, using conference ID: 3544449. A live and archived webcast will be available on the Investors sections of the companys website at: IntriCon Corporation Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe. The companys common stock trades under the symbol IIN on the NASDAQ Global Market. For more information about IntriCon, visit Relations Contact: Leigh Salvo 415 937-5404 